MEMS device and method for delivery of therapeutic agents

Patent metadata

Field	Value
Publication number	US-9693894-B2
Application number	US-201414295102-A
Country	US
Kind code	B2
Filing date	Jun 3, 2014
Priority date	Mar 14, 2006
Publication date	Jul 4, 2017
Grant date	Jul 4, 2017

Abstract

Embodiments of an implantable device for delivering a therapeutic agent to a patient include a reservoir configured to contain a liquid comprising the therapeutic agent, and a cannula in fluid communication with the reservoir. The cannula is shaped to facilitate insertion thereof into a patient's eyeball.

First claim

What is claimed is:

1. An implantable electrolytic pump comprising:
a drug chamber for containing a liquid to be administered;
a cannula in fluid communication with the chamber;
an electrolysis chamber comprising first and second electrodes;
circuitry configured for applying a voltage between the first and second electrodes to facilitate electrolysis of a material in the electrolysis chamber to thereby produce a gas and force the liquid to flow from the drug chamber to the cannula; and
a catalyst in the electrolysis chamber for catalyzing recombination of the produced gas to form the material, thereby reversing the electrolysis;
wherein the circuitry is further configured to apply a small trickle charge to the first and second electrodes to prevent reversing the electrolysis and hold the pump in place.

2. The pump of claim 1 , further comprising a flexible membrane disposed above the electrodes that expands upon production of the gas to thereby force the liquid to flow.

3. The pump of claim 2 , wherein the membrane comprises parylene.

4. The pump of claim 2 , wherein the electrodes and the membrane are contained within the chamber.

5. The pump of claim 1 , further comprising a separate electrolysis chamber, adjacent to the drug chamber, for containing a working fluid sealed therein, the electrodes being disposed in the electrolysis chamber.

6. The pump of claim 1 , wherein the first and second electrodes are both planar.

7. The pump of claim 6 , wherein the first and second electrodes are interdigitated with one another.

8. The pump of claim 1 , wherein the cannula comprises a flow regulator.

9. The pump of claim 8 , wherein the flow regulator comprises a valve.

10. The pump of claim 1 , further comprising a refill port, for facilitating refilling of the pump, in fluid communication with the drug chamber.

11. A method of delivering a therapeutic agent, the method comprising the steps of:
providing a pump comprising (i) a drug chamber containing a liquid to be administered, (ii) a cannula in fluid communication with the chamber, (iii) an electrolysis chamber comprising first and second electrodes, and (iv) circuitry for applying a voltage between the first and second electrodes and for applying a small trickle charge to the first and second electrodes;
applying the voltage to facilitate electrolysis of a material in the electrolysis chamber to cause creation of a gas and force the liquid to flow from the drug chamber through the cannula and thereby deliver the liquid;
providing a catalyst in the electrolysis chamber for catalyzing recombination of the created gas to form the material, thereby reversing the electrolysis; and
applying the small trickle charge to prevent reversing the electrolysis and hold the pump in place.

12. The method of claim 11 , wherein the pump further comprises a flexible membrane disposed above the electrodes that expands upon production of the gas to thereby force the liquid to flow.

13. The method of claim 12 , wherein the membrane comprises a series of radially-concentric corrugations facilitating (a) expansion of the membrane from a substantially flat configuration to an inflated configuration with increases in pressure and (b) contraction of the membrane from the inflated configuration to the substantially flat configuration with decreases in pressure.

14. The method of claim 12 , wherein the electrodes and the membrane are contained within the chamber.

15. The method of claim 11 , wherein the pump further comprises a separate electrolysis chamber adjacent to the drug chamber and the electrodes are disposed in the electrolysis chamber.

16. The method of claim 15 , further comprising providing a working fluid in the electrolysis chamber, wherein applying the voltage energizes the electrodes thereby causing the gas to be created within the electrolysis chamber.

17. The pump of claim 1 , wherein the circuitry is further configured to reverse a polarity of the applied voltage to reverse the production of gas after the trickle charge has been applied.

18. The method of claim 11 , further comprising reversing a polarity of the applied voltage to reverse the production of gas after the trickle charge has been applied.

Assignees

• Tai Yu-Chong
• Humayun Mark
• Shih Jason
• Univ Southern California

Inventors

• Tai Yu-Chong
• Humayun Mark
• Shih Jason

Classifications

• A61M2205/3507

  with implanted devices, e.g. external control · CPC title

• A61F9/0017 Primary

  implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

• F16K99/0057

  the fluid being the circulating fluid itself, e.g. check valves · CPC title

• A61K9/0024

  Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L) · CPC title

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title